NAD+ (Nicotinamide Adenine Dinucleotide)
Research Guide

Research Overview

NAD+ (Nicotinamide Adenine Dinucleotide) is one of the most extensively characterized coenzymes in cell biology. It is an endogenous pyridine dinucleotide, not a peptide, and it sits at the center of cellular energy metabolism in essentially every living cell studied to date. In the research literature it is described in two broad roles: as a redox electron carrier and as a consumed co-substrate for a family of NAD+-dependent enzymes.

As a redox carrier, NAD+ accepts a hydride to form NADH and cycles between its oxidized and reduced states. This cycling drives the electron-transfer steps of glycolysis, the TCA cycle, fatty acid oxidation, and mitochondrial oxidative phosphorylation, and the NAD+/NADH ratio is a widely reported readout of the metabolic and redox state of a cell (per PubMed reviews, Covarrubias et al. 2021 and Navas and Carnero 2021).

Separately, NAD+ is cleaved and consumed by sirtuins, PARPs, and the CD38/CD157 glycohydrolases in studied signaling processes, so cellular pools depend on continuous biosynthesis through the NAMPT salvage pathway and the de novo and Preiss-Handler routes. This guide compiles verified identity data, a mechanism summary, preclinical research applications, and handling notes for laboratory reference. All statements describe in-vitro and preclinical research context only.

Mechanism Summary

Mechanisms reported in the in-vitro and preclinical research literature include:

• Redox carrier. NAD+ accepts a hydride to become NADH and cycles between oxidized (NAD+) and reduced (NADH) forms. In this role it serves as the primary electron carrier across glycolysis, the TCA cycle, fatty acid oxidation, and mitochondrial oxidative phosphorylation. The NAD+/NADH ratio is reported in the literature as a readout of cellular redox balance and metabolic state (Covarrubias et al. 2021, DOI 10.1038/s41580-020-00313-x; Navas and Carnero 2021, DOI 10.1038/s41392-020-00354-w).
• Consumed co-substrate. Distinct from redox recycling, NAD+ is cleaved and consumed by three enzyme families studied in cell and animal models: sirtuins (NAD+-dependent protein deacylases such as SIRT1, implicated in reported deacetylation, chromatin, and stress-response signaling), poly(ADP-ribose) polymerases (PARPs, which consume NAD+ during studied DNA-damage and repair responses), and the NAD+ glycohydrolases/cyclases CD38 and CD157 (reported to generate ADP-ribose and cyclic ADP-ribose second messengers and implicated in immune-cell function).
• Biosynthesis and decline. Because these enzymes consume NAD+ rather than merely recycling it, cellular pools require continuous biosynthesis. The salvage pathway via NAMPT (the rate-limiting step) regenerates most NAD+ from nicotinamide, with de novo and Preiss-Handler routes contributing from tryptophan and niacin. Preclinical literature reports a gradual decline in tissue NAD+ with aging in model organisms and associations with metabolic and aging-related phenotypes, and restoring NAD+ via precursors is studied as an intervention (Covarrubias et al. 2021; Yoshino, Baur and Imai, DOI 10.1016/j.cmet.2017.11.002).
• All mechanism statements above are biochemical or drawn from in-vitro and preclinical studies. None describe a human benefit, therapeutic effect, or clinical outcome.

Reference Data

Identity values are compiled from public chemistry databases and vendor documentation. Confirm the exact salt form, molecular weight, and purity for a given batch against its Certificate of Analysis (COA).

Research Applications

In laboratory research, NAD+ (Nicotinamide Adenine Dinucleotide) is studied in contexts such as:

• Studied as a fundamental redox coenzyme in enzymology and biochemistry assays, including NAD+/NADH-coupled dehydrogenase reactions and spectrophotometric enzyme kinetics.
• Investigated in aging and senescence research as a cofactor whose tissue levels decline with age in preclinical models (reviewed in Covarrubias et al. 2021, DOI 10.1038/s41580-020-00313-x).
• Investigated as a substrate and regulator of sirtuins (NAD+-dependent deacylases) in studies of metabolic and stress-response signaling.
• Investigated as a substrate for PARP enzymes in DNA-damage and repair research.
• Investigated in relation to CD38/CD157 NAD+ glycohydrolases and cyclic ADP-ribose signaling in immunometabolism research.
• Studied in cancer-metabolism research, where NAD+ biosynthesis via NAMPT supports the Warburg-effect glycolytic phenotype and NAMPT inhibition is explored preclinically (Yaku et al. 2018, DOI 10.3389/fonc.2018.00622; Navas and Carnero 2021, DOI 10.1038/s41392-020-00354-w).
• NAD+ together with its precursors NMN and NR studied as NAD+-boosting agents in metabolic and mitochondrial-function research (Yoshino, Baur and Imai, DOI 10.1016/j.cmet.2017.11.002; nicotinamide riboside trial Remie et al. 2020, DOI 10.1093/ajcn/nqaa072, NCT02835664). Related NAD-boosting compounds are under clinical investigation, e.g. the beta-NMN drug MIB-626, studied vs placebo in a Phase 2 COVID-19 trial (NCT05038488); these study precursors rather than NAD+ administered directly.

Storage Information

• Store the lyophilized powder desiccated, protected from light, and frozen at -20C for long-term storage. NAD+ is hygroscopic, so equilibrate the container to room temperature before opening to limit moisture uptake.
• pH-dependent solution stability is the key handling constraint. NAD+ solids are stable when kept dry and dark, but in solution NAD+ is most stable at acidic-to-neutral pH and decomposes rapidly under alkaline conditions. Vendor data indicate an aqueous solution near pH 2.5 to 3 can retain content over several weeks refrigerated, whereas near-neutral solutions are stable only on the order of days at 4C; avoid alkaline buffers.
• Aliquot reconstituted stock and store frozen at -20C, or 4C only for short-term work, to limit hydrolysis and freeze-thaw degradation. Prepare fresh where practical.
• See the Lyophilized Storage Guide for general cold-chain and desiccation practice, and use the Reconstitution Calculator to plan working concentrations. Confirm the exact solubility ceiling, recommended diluent, and shelf life against the batch COA.